retatrutide for autoimmune disease semaglutide and Weight loss, disease activity, and patient reported outcomes in patients with musculoskeletal Retatrutide: The New Triple-Agonist Weight
Description
September 27 Product: Sanofi and Regenerons Dupixent Indication : Chronic obstructive pulmonary disease Sanofi and Regeneron won a seventh indication for their blockbuster drug Dupixent Friday, as it became the first biologic medicine in the U.S
Despite the promise of the GLP-1 friendly label, its lack of regulatory definition poses challenges
A list of software used is available in the Methods section and Reporting Summary
"GLP-1RA initiation linked to new thyroid cancer diagnoses"
This research did not receive any specific Grant from funding agencies
